LivaNova’s (LIVN) “Buy” Rating Reiterated at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of LivaNova (NASDAQ:LIVN) in a report issued on Tuesday morning,Benzinga reports. They currently have a $75.00 target price on the stock.

LIVN has been the topic of several other reports. Stifel Nicolaus boosted their price target on LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, July 25th. Robert W. Baird boosted their price objective on LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a report on Thursday, October 31st. Mizuho decreased their price objective on LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Baird R W upgraded LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th. Finally, The Goldman Sachs Group started coverage on LivaNova in a report on Friday, October 4th. They set a “buy” rating and a $65.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, LivaNova currently has an average rating of “Buy” and an average price target of $69.17.

LivaNova Trading Down 1.6 %

LIVN traded down $0.84 during trading on Tuesday, hitting $51.48. The company’s stock had a trading volume of 62,040 shares, compared to its average volume of 616,950. LivaNova has a twelve month low of $42.75 and a twelve month high of $64.47. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. The stock’s fifty day moving average price is $51.67 and its 200-day moving average price is $52.98. The firm has a market capitalization of $2.80 billion, a P/E ratio of 123.95 and a beta of 1.01.

Institutional Investors Weigh In On LivaNova

Several institutional investors have recently bought and sold shares of LIVN. Point72 Asset Management L.P. grew its holdings in LivaNova by 204.3% during the second quarter. Point72 Asset Management L.P. now owns 1,285,636 shares of the company’s stock worth $70,479,000 after buying an additional 863,157 shares in the last quarter. First Light Asset Management LLC grew its holdings in LivaNova by 591.1% during the second quarter. First Light Asset Management LLC now owns 710,390 shares of the company’s stock worth $38,944,000 after buying an additional 607,598 shares in the last quarter. Great Lakes Advisors LLC bought a new stake in LivaNova during the second quarter worth $16,614,000. Driehaus Capital Management LLC grew its holdings in LivaNova by 64.7% during the second quarter. Driehaus Capital Management LLC now owns 544,042 shares of the company’s stock worth $29,824,000 after buying an additional 213,749 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its holdings in LivaNova by 286.4% during the third quarter. The Manufacturers Life Insurance Company now owns 207,248 shares of the company’s stock worth $10,889,000 after buying an additional 153,611 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.